V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230002071 | 230010694 | 1.6 | 99 | null | 2021-05-26 | 2021-06-18 | PACLITAXEL | 02 | null | PACLITAXEL | 100560032 |
| 230002075 | 230010696 | 1.62 | 78 | null | 2022-05-09 | 2022-05-09 | Paclitaxel 7 day | 02 | null | PACLITAXEL | 101208932 |
| 230002078 | 230010697 | 1.74 | 52 | null | null | 2019-12-25 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101221344 |
| 230002089 | 230010698 | 1.67 | 62.7 | null | null | 2021-05-23 | PEMBROLIZUMAB | 02 | null | DABRAFENIB + TRAMETINIB | 101402009 |
| 230002095 | 230010699 | null | null | null | 2018-03-23 | 2020-09-06 | Olaparib | 02 | null | OLAPARIB | 100288931 |
| 230002096 | 230010700 | 1.63 | 84.9 | null | null | 2021-07-16 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100069176 |
| 230002098 | 230010701 | 1.59 | 67 | Palliative (P) | 2021-11-16 | 2022-05-05 | Azacitidine | 02 | N | CISPLATIN + PACLITAXEL | 101686199 |
| 230002109 | 230010704 | 1.56 | 73.7 | null | 2021-05-03 | 2021-12-19 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100812027 |
| 230002112 | 230010705 | 1.7 | 78.15 | Palliative (P) | 2018-02-25 | 2018-04-08 | Bevacizumab 7.5mg/kg | 02 | N | BEVACIZUMAB | 101610339 |
| 230002114 | 230010706 | 1.58 | 65 | null | 2021-09-26 | 2021-11-02 | null | N | null | PACLITAXEL | 101016107 |
| 230002117 | 230010707 | 1.52 | 68.7 | Palliative (P) | 2021-10-18 | 2021-11-19 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 100477391 |
| 230002124 | 230010709 | 1.66 | 69.4 | null | 2020-06-29 | 2020-07-04 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100318201 |
| 230002128 | 230010710 | null | null | null | 2020-10-22 | 2020-11-07 | Rucaparib | 02 | null | RUCAPARIB | 100303037 |
| 230002134 | 230010712 | 1.5 | 93 | Palliative (P) | null | 2022-04-21 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100359729 |
| 230002139 | 230010713 | 1.62 | 63.2 | Palliative (P) | null | 2020-04-01 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 100761734 |
| 230002144 | 230010715 | 1.66 | 73.2 | Adjuvant (A) | 2021-05-08 | 2021-05-09 | null | null | N | NIRAPARIB | 100159162 |
| 230002150 | 230010718 | 1.53 | 95.7 | null | 2021-02-18 | 2022-04-05 | GEMCARBO | 02 | null | CARBOPLATIN + GEMCITABINE | 100633493 |
| 230002159 | 230010719 | null | null | Palliative (P) | 2019-10-11 | 2019-11-07 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101786518 |
| 230002164 | 230010720 | 1.69 | 61.5 | null | 2018-09-17 | 2021-03-07 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100317806 |
| 230002179 | 230010722 | null | null | Palliative (P) | null | 2021-11-07 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100556662 |
| 230002191 | 230010724 | 1.67 | 74.2 | Palliative (P) | null | 2021-12-31 | Niraparib | null | N | CARBOPLATIN + GEMCITABINE | 101547711 |
| 230002213 | 230010725 | 1.66 | 50.1 | null | 2021-08-31 | 2021-09-01 | CARBOPLATIN + GEMCITABINE | 02 | null | CARBOPLATIN + GEMCITABINE | 100396177 |
| 230002219 | 230010726 | null | 61 | null | 2019-09-04 | 2021-06-27 | null | null | null | NIRAPARIB | 100788570 |
| 230002226 | 230010728 | 1.61 | 73.1 | Curative (C) | 2021-10-19 | 2022-05-25 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100126004 |
| 230002233 | 230010729 | 1.5 | 67 | Palliative (P) | 2021-09-07 | 2021-09-14 | CARBOPLATIN | 02 | N | CARBOPLATIN | 101079093 |
| 230002236 | 230010731 | null | null | null | 2022-02-05 | 2022-02-15 | null | 02 | null | CISPLATIN | 100590159 |
| 230002237 | 230010732 | 1.66 | 53.2 | null | 2019-10-12 | 2019-10-13 | null | 02 | null | CISPLATIN | 100107581 |
| 230002257 | 230010733 | 1.5 | 58.8 | null | null | 2022-01-26 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 100731899 |
| 230002258 | 230010734 | null | null | null | null | 2020-06-20 | Trabectedin | 02 | null | TRIAL UNSPECIFIED | 100778972 |
| 230002286 | 230010739 | 1.66 | 70.3 | null | null | 2020-04-02 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 100750655 |
| 230002327 | 230010743 | null | null | null | 2018-08-23 | 2018-09-12 | null | null | null | BEVACIZUMAB | 100739585 |
| 230002336 | 230010744 | 1.58 | 89 | Adjuvant (A) | 2018-03-20 | 2019-01-18 | null | null | N | PEMBROLIZUMAB | 100995690 |
| 230002345 | 230010747 | 1.54 | 86.9 | null | 2021-07-13 | 2021-07-13 | Carboplatin + Liposomal Doxorubicin | 02 | null | TEMOZOLOMIDE | 100861950 |
| 230002349 | 230010748 | 1.6 | null | null | null | 2021-02-12 | Olaparib | 02 | null | OLAPARIB | 100379957 |
| 230002354 | 230010749 | 1.53 | 53.8 | null | 2021-10-11 | 2021-10-20 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101815667 |
| 230002362 | 230010750 | null | 101 | null | 2021-10-19 | 2021-11-01 | PACLITAXEL | 02 | null | PACLITAXEL | 100665034 |
| 230002368 | 230010751 | 1.53 | 79 | null | 2021-02-18 | 2021-02-21 | PACLITAXEL | 02 | null | PACLITAXEL | 100273349 |
| 230002390 | 230010753 | null | null | null | 2021-04-17 | 2021-04-26 | null | N | null | CARBOPLATIN + GEMCITABINE | 100193772 |
| 230002396 | 230010754 | null | null | null | 2019-06-30 | 2019-10-22 | null | null | null | BEVACIZUMAB + CARBO + PACLITAXEL | 100908412 |
| 230002409 | 230010755 | 1.64 | 104 | Adjuvant (A) | 2020-10-18 | 2021-02-14 | null | 02 | N | TRIAL UNSPECIFIED | 100843848 |
| 230002410 | 230010756 | 1.61 | 48 | null | 2020-08-07 | 2020-08-11 | Bevacizumab | 02 | null | BEVACIZUMAB | 100477175 |
| 230002411 | 230010757 | 1.56 | 71.65 | null | 2022-03-10 | 2022-03-14 | null | 01 | null | NIRAPARIB | 101215995 |
| 230002412 | 230010758 | 1.65 | 76.4 | null | 2016-08-19 | 2017-06-12 | PACLITAXEL | 02 | null | PACLITAXEL | 101528187 |
| 230002438 | 230010760 | 1.56 | 49.5 | null | 2021-11-28 | 2022-02-01 | ICON8B TRIAL | 2 | null | PEMBROLIZUMAB | 100242657 |
| 230002456 | 230010762 | 1.58 | 53 | Palliative (P) | 2021-03-07 | 2021-03-08 | null | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101871570 |
| 230002460 | 230010764 | null | null | Palliative (P) | 2019-12-01 | 2020-03-09 | NIVOLUMAB | N | N | BEVACIZUMAB | 100702198 |
| 230002462 | 230010765 | 1.58 | 63.5 | null | null | 2020-09-01 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100217599 |
| 230002475 | 230010767 | 1.71 | 80 | Palliative (P) | 2020-10-26 | 2020-11-02 | CARBOPLATIN + GEMCITABINE | 02 | N | CARBOPLATIN + GEMCITABINE | 101761464 |
| 230002484 | 230010769 | 1.7 | 66 | null | 2018-09-14 | 2018-09-26 | Niraparib | 02 | null | NIRAPARIB | 101190704 |
| 230002486 | 230010770 | 1.59 | 59.4 | null | 2020-04-14 | 2020-04-17 | null | 02 | null | PEMBROLIZUMAB | 100313597 |